ADIM
AME icon

Alpha DNA Investment Management’s Ametek AME Stock Holding History

Alpha DNA Investment Management’s Portfolio AME Stock Details AME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,595
Closed -$1.07M – 172
2023
Q2 		$1.07M Buy
+6,595
New +$963K 0.36% 61
2023
Q1 		– Sell
-9,518
Closed -$1.33M – 151
2022
Q4 		$1.33M Buy
+9,518
New +$1.26M 0.47% 54
2022
Q1 		– Sell
-12,700
Closed -$1.87M – 118
2021
Q4 		$1.87M Buy
+12,700
New +$1.74M 1.18% 16

Other funds holding AME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Alpha DNA Investment Management's AME Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Ametek (AME) in Q3 2023, closing a stake of 6,595 shares — an estimated $1.07M sold.

Alpha DNA Investment Management first reported a position in AME in Q4 2021 and held it in 3 quarters. The position peaked at $1.87M in Q4 2021. 812 funds tracked by Wall St. Rank hold AME as of Q3 2023.

  • Alpha DNA Investment Management reported no remaining Ametek position as of Q3 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 6,595 Ametek shares in Q3 2023, an estimated $1.07M.
  • Alpha DNA Investment Management first reported a position in Ametek in Q4 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's Ametek position peaked at $1.87M in Q4 2021.
  • 812 funds tracked by Wall St. Rank held Ametek as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.